These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26760587)

  • 1. Review of imaging techniques in the diagnosis of hepatocellular carcinoma in patients who require a liver transplant.
    Villacastín Ruiz E; Caro-Patón Gómez A; Calero Aguilar H; Pérez Saborido B; García Pajares F; Sánchez Antolín G; Madrigal Rubiales B; Pacheco Sánchez D; Pintado Garrido R; Plaza Loma S; Escudero Caro T
    Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):412-20. PubMed ID: 26760587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators.
    Bhattacharjya S; Bhattacharjya T; Quaglia A; Dhillon AP; Burroughs AK; Patch DW; Tibballs JM; Watkinson AF; Rolles K; Davidson BR
    Dig Surg; 2004; 21(2):152-9; discussion 159-60. PubMed ID: 15166485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Accuracy of multislice computed tomography in the diagnosis of hepatocellular carcinoma in patients with cirrhosis evaluated for liver transplantation].
    Haberman D; Mela M; Martínez A; Mancinelli A; Laguens R; Gruz F; Gondolesi G
    Acta Gastroenterol Latinoam; 2011 Sep; 41(3):190-8. PubMed ID: 22232996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of recurrent hepatocellular carcinoma on post-operative surveillance: comparison of MDCT and gadoxetic acid-enhanced MRI.
    Kim KA; Kim MJ; Choi JY; Park MS; Lim JS; Chung YE; Kim KW
    Abdom Imaging; 2014 Apr; 39(2):291-9. PubMed ID: 24384804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma in liver transplantation candidates: detection with gadobenate dimeglumine-enhanced MRI.
    Choi SH; Lee JM; Yu NC; Suh KS; Jang JJ; Kim SH; Choi BI
    AJR Am J Roentgenol; 2008 Aug; 191(2):529-36. PubMed ID: 18647927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of hepatic MDCT, MRI, and DSA to explant pathology for the detection and treatment planning of hepatocellular carcinoma.
    Ladd LM; Tirkes T; Tann M; Agarwal DM; Johnson MS; Tahir B; Sandrasegaran K
    Clin Mol Hepatol; 2016 Dec; 22(4):450-457. PubMed ID: 27987537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.
    Lee DH; Lee JM; Baek JH; Shin CI; Han JK; Choi BI
    Radiology; 2015 Jan; 274(1):149-60. PubMed ID: 25203131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic performance of multidetector row computed tomography, superparamagnetic iron oxide-enhanced magnetic resonance imaging, and dual-contrast magnetic resonance imaging in predicting the appropriateness of a transplant recipient based on milan criteria: correlation with histopathological findings.
    Lee DH; Kim SH; Lee JM; Park HS; Lee JY; Yi NJ; Suh KS; Jang JJ; Han JK; Choi BI
    Invest Radiol; 2009 Jun; 44(6):311-21. PubMed ID: 19462486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of hepatocellular carcinoma detection on multidetector CT in a transplant liver population with explant liver correlation.
    Addley HC; Griffin N; Shaw AS; Mannelli L; Parker RA; Aitken S; Wood H; Davies S; Alexander GJ; Lomas DJ
    Clin Radiol; 2011 Apr; 66(4):349-56. PubMed ID: 21295772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Staging of hepatocellular carcinoma. Comparison of ultrasonography, computerized tomography, magnetic resonance, digital angiography, and computerized tomography with lipiodol].
    Bartolozzi C; Lencioni R; Caramella D; Gibilisco G; Cioni R; Vignali C
    Radiol Med; 1994 Oct; 88(4):429-36. PubMed ID: 7997616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast imaging techniques to diagnose hepatocellular carcinoma in cirrhotics outside regular surveillance.
    Iavarone M; Viganò M; Piazza N; Occhipinti V; Sangiovanni A; Maggioni M; D'Ambrosio G; Forzenigo LV; Motta F; Lampertico P; Rumi MG; Colombo M
    Ann Hepatol; 2019; 18(2):318-324. PubMed ID: 31036496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additional value of gadoxetic acid-DTPA-enhanced hepatobiliary phase MR imaging in the diagnosis of early-stage hepatocellular carcinoma: comparison with dynamic triple-phase multidetector CT imaging.
    Haradome H; Grazioli L; Tinti R; Morone M; Motosugi U; Sano K; Ichikawa T; Kwee TC; Colagrande S
    J Magn Reson Imaging; 2011 Jul; 34(1):69-78. PubMed ID: 21598343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma in cirrhotic patients: prospective comparison of US, CT and MR imaging.
    Di Martino M; De Filippis G; De Santis A; Geiger D; Del Monte M; Lombardo CV; Rossi M; Corradini SG; Mennini G; Catalano C
    Eur Radiol; 2013 Apr; 23(4):887-96. PubMed ID: 23179521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of discordant findings between hepatic angiography and cross-sectional imaging in transplant candidates with hepatocellular carcinoma.
    Young K; Fidelman N; Yao FY; Hills NK; Kohi MP; Kolli KP; Taylor AG; Kerlan RK
    Liver Transpl; 2015 Apr; 21(4):454-67. PubMed ID: 25678220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 11C-acetate and 18F-FDG PET/CT for clinical staging and selection of patients with hepatocellular carcinoma for liver transplantation on the basis of Milan criteria: surgeon's perspective.
    Cheung TT; Ho CL; Lo CM; Chen S; Chan SC; Chok KS; Fung JY; Yan Chan AC; Sharr W; Yau T; Poon RT; Fan ST
    J Nucl Med; 2013 Feb; 54(2):192-200. PubMed ID: 23321459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic imaging of hepatocellular carcinoma in patients with cirrhosis before liver transplantation.
    Taouli B; Krinsky GA
    Liver Transpl; 2006 Nov; 12(11 Suppl 2):S1-7. PubMed ID: 17051556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-weighted MRI as a screening tool for hepatocellular carcinoma in cirrhotic livers: correlation with explant data-a pilot study.
    McNamara MM; Thomas JV; Alexander LF; Little MD; Bolus DN; Li YE; Morgan DE
    Abdom Radiol (NY); 2018 Oct; 43(10):2686-2692. PubMed ID: 29500648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of hepatocellular carcinoma by Gd-EOB-DTPA-enhanced liver MRI: comparison with triple phase 64 detector row helical CT.
    Akai H; Kiryu S; Matsuda I; Satou J; Takao H; Tajima T; Watanabe Y; Imamura H; Kokudo N; Akahane M; Ohtomo K
    Eur J Radiol; 2011 Nov; 80(2):310-5. PubMed ID: 20732773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gd-EOB-DTPA-enhanced MRI is better than MDCT in decision making of curative treatment for hepatocellular carcinoma.
    Yoo SH; Choi JY; Jang JW; Bae SH; Yoon SK; Kim DG; Yoo YK; Rha SE; Lee YJ; Jung ES
    Ann Surg Oncol; 2013 Sep; 20(9):2893-900. PubMed ID: 23649931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the Detection of hepatocellular carcinoma in patients with cirrhosis.
    Di Martino M; Marin D; Guerrisi A; Baski M; Galati F; Rossi M; Brozzetti S; Masciangelo R; Passariello R; Catalano C
    Radiology; 2010 Sep; 256(3):806-16. PubMed ID: 20720069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.